go back

Ciltacabtagene Autoleucel (Carvykti) CAR-T Therapy

New Mexico rates for HCPCS Q2056

Ciltacabtagene autoleucel, up to 100 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated October 2026.

How much rates vary

Facilitymedian $2,884,032 · 10th to 90th $831,764 to $4,570,882Professionalmedian $741,310 · 10th to 90th $588,844 to $741,310
$1M$2M$5Mfacility $2,884,032professional $741,310

Distribution of negotiated rates across all payers (price axis is log-scale). Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Facility
Modifier
None
Typical Low
$588,843.66
Median
$588,843.66
Typical High
$588,843.66
Aetna
Setting
Professional
Modifier
None
Typical Low
$588,843.66
Median
$741,310.24
Typical High
$741,310.24
BCBS New Mexico
Setting
Facility
Modifier
None
Typical Low
$831,763.77
Median
$2,884,031.50
Typical High
$4,570,881.90